Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body and neurodevelopmental conditions...
Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30 January 2022 – 31 March 2022 (EARTH-B Trial) 1 October 2021 – 31...
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional...
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional...
LAS VEGAS, July 20 /PRNewswire/ -- SmallCapSentinel.com has just released an article addressing the market direction over the next 60 days, fusing bull, bearish and flat market perspectives into...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -2.67857142857 | 5.6 | 6.1 | 5.41 | 23346 | 5.70112 | CS |
4 | -0.72 | -11.6693679092 | 6.17 | 6.71 | 5.4 | 67051 | 6.02305535 | CS |
12 | -0.89 | -14.0378548896 | 6.34 | 12.5 | 4.18 | 118739 | 6.32882572 | CS |
26 | 0.68 | 14.2557651992 | 4.77 | 32.44 | 3 | 151865 | 9.72623035 | CS |
52 | -4.94 | -47.5457170356 | 10.39 | 32.44 | 3 | 77824 | 9.65173617 | CS |
156 | -22.83 | -80.7284299859 | 28.28 | 48.29 | 3 | 30219 | 12.42335291 | CS |
260 | -6.55 | -54.5833333333 | 12 | 59 | 3 | 88941 | 26.11868905 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales